Stage III Diffuse Large B-Cell Lymphoma
3 clinical trials · Condition
◉ Watch Stage III Diffuse Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma (NCT02541565) | University of Washington | 2015-11-24 |
| Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission (NCT02530125) | Northwestern University | 2015-09-01 |
| Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma (NCT01959698) | Roswell Park Cancer Institute | 2014-04-17 |
Track Stage III Diffuse Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.